Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels.

(Alliance News) - Ananda Pharma PLC on Tuesday said the first subject has been dosed in the phase 1 pharmacokinetic study for its lead cannabidiol drug candidate, MRX1. Ananda is a London-based ...

Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.

A new multicenter study has found that highly purified cannabidiol (CBD) significantly reduces seizure frequency in patients ...

A woman who failed a random drug test at work after taking 'THC free' CBD gummies has learned she will KEEP her job.

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

Around 5% of healthy adults exposed to cannabidiol show elevated liver enzyme levels exceeding the normal threshold alongside ...

An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising safety concerns.

Patients with LGS and DS might benefit from highly purified cannabidiol (CBD) to a greater extent than initially thought, a study found.

In vitro tests indicate that cannabidiol can stimulate the biomineralization of teeth even under inflammatory conditions, thus promoting tissue repair. In the experiment, cells from the dental ...

LOS ANGELES — Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show. The BECOME-TSC study evaluated outcomes of ...

LOS ANGELES — Treatment with cannabidiol in young people with tuberous sclerosis complex led to significant improvements in several cognitive, behavioral and executive domains, data from ongoing ...